• Education
  • |
  • Points
  • Get the app
  • Country
    singapore
    hong kong
    malaysia
    indonesia
    thailand
    philippines
    vietnam
    india

    australia
    korea
    new zealand
The MIMS logo.
  • Home
  • Find Drugs
  • Pill Identifier
  • Find Drug Company
  • Diseases
  • Medical News & Updates
The MIMS logo.
Home Find Drugs Pill Identifier Find Drug Company Diseases Medical News & Updates
Other Services
MIMS Education MIMS Points Download App
Country
  • a globesingapore
  • a globemalaysia
  • a globeindonesia
  • a globethailand
  • a globephilippines
  • a globevietnam
  • a globeindia
  • a globeaustralia
  • a globekorea
  • a globenew zealand
The MIMS logo.
Molecular structure pattern
  1. Home icon
  2. Diseases
  3. Amyotrophic Lateral Sclerosis
    • Diseases
    • Amyotrophic Lateral Sclerosis
  4. Follow Up

Amyotrophic Lateral Sclerosis Follow Up

Last updated: 18 May 2026
Reviewed by
PAGINATION TESTMIMS Neurology Honorary Editorial Advisory Board
Follow Up
Monitoring
OverviewHistory and Physical ExaminationDiagnosisManagement
IntroductionEpidemiologyPathophysiologyRisk Factors
Clinical PresentationDiagnosis or Diagnostic Criteria
Laboratory Tests and AncillariesImaging
Differential Diagnosis
Pharmacological therapyNonpharmacological
Monitoring
Neurodegenerative Disease DrugsMuscle RelaxantsDisclaimerRelated MIMS Drugs
OverviewHistory and Physical ExaminationDiagnosisManagement
IntroductionEpidemiologyPathophysiologyRisk Factors
Clinical PresentationDiagnosis or Diagnostic Criteria
Laboratory Tests and AncillariesImaging
Differential Diagnosis
Pharmacological therapyNonpharmacological
Monitoring
Neurodegenerative Disease DrugsMuscle RelaxantsDisclaimerRelated MIMS Drugs

Monitoring

Visits are scheduled every 2-3 months to monitor and manage progression of the disease. Repeated assessments for frontotemporal cognitive impairment from the time of ALS diagnosis is recommended. Pulmonary function tests should be routinely done to assess for respiratory decline. Weight is monitored and routine assessment for dysphagia and nutrition is done. Lastly, patients are assessed for spasticity, pain, mobility, and activities of daily living. 

The MIMS logo.
  • Drugs
  • Find Drugs
  • Pill Identifier
  • Find Drug Company
  • MIMS Abbreviation Index
  • Diseases
  • Search Disease Information
  • Editorial Advisory Board
  • Medical News & Updates
  • Latest News & Updates
  • More Services
  • Education
  • Points
  • Subscribe
  • About
  • MIMS Corporate
  • Terms of Use
  • Privacy Policy
  • Feedback
Connect with MIMS
A social media brand icon.A social media brand icon.
TUV Nord ISO 9001 certification logo
MIMS Specialty release/v3.16.0_3176.1
Copyright © 2026 MIMS Pte Ltd. All rights reserved. UAT
MIMS Logo

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?
Something went wrong.